Ahmed is responsible for supporting The Policy Authority’s Policy Search and Policy Monitor, finding new solutions for business dilemmas and ensures that Verden remains at the forefront of innovative solutions for our clients. With a primary role in market research, analytics and marketing activities, he is our primary resource for research and analysis of industry data and managed care insurance companies.
A great asset, Ahmed brings a diverse skill set to The Verden Group, educated in Marketing with experience in customer service and operations management.In addition to his work at The Verden Group, Ahmed also manages his own consulting company, Northern Sky, in Lahore, Pakistan.
Outsourcing chronic care management can have many benefits for small practices. Here are tips on how to successfully implement a CCM program that would be advantageous for both your practice and patients.
"Successfully implementing a CCM program starts with laying the operational groundwork: integrating new staff and installing healthIT software. Committing time and resources into integrating remote care managers early on is critical to reaping the benefits long term. By treating remote care coordinators as true extensions of your staff, adapting to the culture, tone, and workflow of your practice, they eventually become integral parts of practice operations, and in some cases, may even be willing to work in the office a few days a week to get additional face-to-face time with practice staff and patients. This frees up existing staff to manage other important tasks."
Pfizer reports positive results for COVID-19 vaccine in children. Read the latest here.
"Pfizer and COVID-19 vaccine development partner BioNTech reported Monday positive topline results from a pivotal trial of the vaccine in children aged 5 to 11 years. The vaccine was determined to be safe and well tolerated in the youngest age group yet to receive the 2-shot series, according to a Pfizer press statement.
Results of the phase 2/3 trial showed a robust neutralizing antibody response to the 2-dose regimen of 10 µg administered 21 days apart—a dose smaller than the 30-µg given to people aged ≥12 years. The antibody responses among the younger volunteers were comparable to that seen in trials of the vaccine in those aged 16 to 25 years, according to the company. Side effects, too, were comparable to those seen in the older cohort."
The AAP has new recommendations for using consistent terminology to describe and classify unexpected and unexplained infant deaths.
"Throughout the years, many new terms have been used to classify infant deaths to reflect whether they are believed to be accidental or undetermined or fall under other categories," said Dr. Vincent J. Palusci, MD, MS, FAAP, a co-author of the report.
"This has led to inconsistencies in terms used, which in turn increases the chances of communication errors and misunderstandings. Our goal is to establish uniform and shared terminology so that we can best support families after their loss and work to prevent more deaths."